Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$11.29 USD
+0.29 (2.64%)
Updated Sep 20, 2024 04:00 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | 0.07 |
EPS Last Quarter | 0.06 |
Last EPS Surprise | 100.00% |
ABR | 1.31 |
Earnings ESP
|
-16.28% |
---|---|
Current Year | 0.21 |
Next Year | 0.53 |
EPS (TTM) | -0.14 |
P/E (F1) | 53.76 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 133.91M | 143.82M | 514.81M | 633.23M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 135.56M | 148.15M | 520.78M | 662.50M |
Low Estimate | 132.60M | 140.27M | 510.35M | 601.42M |
Year ago Sales | 103.50M | 115.08M | 399.36M | 514.81M |
Year over Year Growth Est. | 29.38% | 24.98% | 28.91% | 23.00% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.07 | 0.09 | 0.21 | 0.53 |
# of Estimates | 6 | 6 | 6 | 6 |
Most Recent Consensus | 0.06 | 0.07 | 0.17 | 0.38 |
High Estimate | 0.12 | 0.16 | 0.35 | 0.84 |
Low Estimate | 0.04 | 0.06 | 0.15 | 0.38 |
Year ago EPS | -0.07 | -0.11 | -0.51 | 0.21 |
Year over Year Growth Est. | 200.00% | 181.82% | 141.18% | 152.38% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 2 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 0 |
Down Last 60 Days | 1 | 3 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.07 | 0.09 | 0.21 | 0.53 |
7 Days Ago | 0.07 | 0.09 | 0.21 | 0.53 |
30 Days Ago | 0.07 | 0.09 | 0.20 | 0.53 |
60 Days Ago | 0.07 | 0.09 | 0.20 | 0.53 |
90 Days Ago | 0.07 | 0.09 | 0.20 | 0.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.06 | 0.08 | 0.18 | 0.42 |
Zacks Consensus Estimate | 0.07 | 0.09 | 0.21 | 0.53 |
Earnings ESP | -16.28% | -13.46% | -14.29% | -21.70% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.06 | -0.02 | -0.11 | -0.07 | NA |
Estimate | 0.03 | -0.06 | -0.06 | -0.08 | NA |
Difference | 0.03 | 0.04 | -0.05 | 0.01 | 0.01 |
Surprise | 100.00% | 66.67% | -83.33% | 12.50% | 23.96% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more